Kevin Ou
About Kevin Ou
Kevin Ou serves as the Director of Formulation Solutions at Precision NanoSystems Inc. in Vancouver, Canada, a role he has held since 2019, following his previous position as Senior Manager of Pharmaceutical Operations.
Work at Precision NanoSystems
Kevin Ou serves as the Director of Formulation Solutions at Precision NanoSystems Inc., a role he has held since 2019. In this position, he is responsible for overseeing formulation strategies and solutions that support the company's mission in the biotechnology sector. His work contributes to the development of innovative drug delivery systems and nanomedicine applications. Prior to this role, he was the Senior Manager of Pharmaceutical Operations at the same company, where he gained extensive experience in pharmaceutical processes and operations.
Education and Expertise
Kevin Ou holds a Master of Applied Science (MASc) from The University of British Columbia, where he studied from 2009 to 2011. He also earned a Bachelor of Engineering and Management from McMaster University, completing his studies from 2003 to 2010. His educational background provides him with a strong foundation in engineering principles and management practices, which he applies in his current role in formulation solutions.
Background
Kevin Ou has a diverse educational and professional background that spans over a decade. He began his academic journey at McMaster University, where he developed a solid understanding of engineering and management. After completing his undergraduate studies, he pursued a master's degree at The University of British Columbia, further enhancing his expertise in applied science. His career at Precision NanoSystems has allowed him to focus on pharmaceutical operations and formulation solutions.
Professional Experience
Before becoming the Director of Formulation Solutions, Kevin Ou held the position of Senior Manager of Pharmaceutical Operations at Precision NanoSystems. This role allowed him to gain significant experience in managing pharmaceutical projects and operations. His transition to the director position reflects his growth within the company and his commitment to advancing formulation strategies in the biotechnology field.